Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
52
NMPA:52
Drug Approvals
Risperidone Orally Disintegrating Tablets
- Product Name
- 利培酮口崩片
- Approval Number
- 国药准字H20249062
- Approval Date
- Oct 16, 2024
NMPA
Xanthinol Nicotinate and Glucose Injection
- Product Name
- 怡汀
- Approval Number
- 国药准字H20041180
- Approval Date
- Nov 8, 2023
NMPA
Dextran 40 and Glucose Injection
- Product Name
- 右旋糖酐40葡萄糖注射液
- Approval Number
- 国药准字H23020619
- Approval Date
- Nov 8, 2023
NMPA
Norfloxacin and Glucose Injection
- Product Name
- 诺氟沙星葡萄糖注射液
- Approval Number
- 国药准字H23020613
- Approval Date
- Nov 8, 2023
NMPA
Dextran 20 and Glucose Injection
- Product Name
- 右旋糖酐20葡萄糖注射液
- Approval Number
- 国药准字H19993564
- Approval Date
- Nov 8, 2023
NMPA
Compound Amino Acid Injection(18AA)
- Product Name
- 复方氨基酸注射液(18AA)
- Approval Number
- 国药准字H19993951
- Approval Date
- Nov 8, 2023
NMPA
Ofloxacin and Sodium Chloride Injection
- Product Name
- 氧氟沙星氯化钠注射液
- Approval Number
- 国药准字H23020618
- Approval Date
- Oct 29, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
No trials found
News
No news found